Galectin Therapeutics Inc SEC filings GALT
Galectin Therapeutics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Oct 18, 2011. Its latest annual report, Form ARS, was filed on Oct 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Mar 31, 2026 | — |
| S-3 | Shelf registration | Apr 14, 2023 | — |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| S-8 | Employee stock plan registration | Nov 9, 2020 | — |
| S-3 | Shelf registration | May 11, 2020 | — |
| S-3 | Shelf registration | Aug 9, 2019 | — |
| FWP | Free writing prospectus | May 10, 2019 | — |
| 424B1 | Form 424(b)(1) | Apr 30, 2019 | — |
| S-3/A | Form s-3/a | Apr 12, 2019 | — |
| S-3/A | Form s-3/a | Apr 8, 2019 | — |
| S-3/A | Form s-3/a | Mar 20, 2019 | — |
| S-3 | Shelf registration | Mar 6, 2019 | — |
| 424B3 | Prospectus | Sep 25, 2018 | — |
| S-3/A | Form s-3/a | Aug 24, 2018 | — |
| S-3 | Shelf registration | Jul 27, 2018 | — |
| S-8 | Employee stock plan registration | Jun 26, 2018 | — |
| S-3 | Shelf registration | May 19, 2017 | — |
| 424B3 | Prospectus | Oct 5, 2016 | — |
| S-3/A | Filing | Aug 31, 2016 | — |
| S-3 | Shelf registration | Aug 15, 2016 | — |
| 424B3 | Prospectus | May 3, 2016 | — |
| S-3 | Shelf registration | Dec 21, 2015 | — |
| 424B5 | Prospectus supplement | Nov 20, 2015 | — |
| S-8 | Employee stock plan registration | Aug 12, 2014 | — |
| S-3 | Shelf registration | Mar 21, 2014 | — |
| 424B5 | Prospectus supplement | Oct 25, 2013 | — |
| POS AM | Post-effective amendment no. 3 to form s-1 on form s-3 | Jan 4, 2013 | — |
| 424B2 | Prospectus | Mar 23, 2012 | — |
| 424B5 | Prospectus supplement | Mar 6, 2012 | — |
| POS AM | Post effective amendment no.2 to form s-1 | Jan 20, 2012 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Nov 15, 2011 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GALT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Norcross, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1133416
- Former names
- PRO PHARMACEUTICALS INC (until May 26, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.